• Online only

Daylong Actinica lotion 80 g

in stock

The first broad spectrum sunscreen liposomal technology with proven clinical absolute protective activity in high-risk groups.The Daylong sunscreen product is only combining liposomal action with the broad spectrum photostable filters organic Tinosorb S and M.

 Customer ratings and reviews
Nobody has posted a review yet
in this language

The first series of sunscreen with liposomal technology that targets the deeper layers of the skin resulting in complete protection from the harmful effects of solar radiation. Organic broad spectrum (UVA and UVB radiation) photostable sun filters Tinosorb S and M are committed to internal liposome, which carries them deeper and in greater concentrations in the stratum corneum. In this way the filters not only become more resistant to water, abrasion and sweat, but ensure considerably more time to stay in the skin, providing optimal sun protection! The Daylong actinica is the only sunscreen clinically proven to drastically reduce the risk of non-melanoma skin cancers (NMSCs).

Suitable for: minor skin, laser, nevi, Photodermatitis-polymorph fotoexanthima, clinically proven prevention NMSCs (non-melanoma cancers), extreme exposure conditions (skiing, water sports, long exposure profession), sensitive skin, immunosuppressive therapy after organ transplantation,Hepatitis B & C, HIV, Treatment for rheumatic or chronic inflammatory diseases, family history of skin cancer, recent scars, prevention of drug photosensitivity, Open photocopy, actinic keratosis, squamous cell carcinoma, burns, atopic dermatitis, lupus erythematosus, Pigmented lesions.
In a period exceeding two years, patients who used Daylong actinica only once a day, not only presented new cases of actinic keratosis, but there was a reduction in their numbers by 53%. In a period exceeding two years, patients who used Daylong actinica only once a day, no new incident squamous cell carcinoma presented (SCC).


Be the first to write your review !